Featured articles
Specially written reviews on the most exiting new findings in glycobiology. For Nature Group Publishing articles, free full access to the publication will be maintained for three months.
March 2008
Drug development: Sweet talk to receptors
Using glycan ligand engineering to target carbohydrate-binding receptors is a promising strategy for stem cell therapy and cancer immunotherapy.
Original research paper: Nature Medicine 14, 181-187 (2008)
doi:10.1038/nm1703Dendritic cell receptors: Keeping it in the family
The dendritic cell (DC) C-lectin-like immune receptor (DCIR) is closely related to other C-lectin like receptors (CLRs) in its antigen presentation function and inhibitory cross talk with Toll-like receptors (TLRs).
Original research paper: Nature Medicine 14, 176-180 (2008)
doi:10.1038/nm1697